Skip to main content

Milestone 6.E

Initiate first in human, phase I drug trials for therapeutic agents against at least 6 novel therapeutic targets. These trials will provide evidence of safety and target engagement.


Success Criteria

  • Completion of 12 phase I drug trials for agents against 6 novel targets, providing conclusive evidence of safety and target engagement.


Research Implementation Area
Drug Development - Novel Targets
Timeline
2017–2023
Status
In Progress

Implementation Activities

Funding Initiatives

Research Programs and Resources

Relevant Recommendations